In this video, Sid P. Kerkar, MD, Exuma Biotech, West Palm Beach, FL, discusses the generation of chimeric antigen receptor T-cells (CAR-T) in vivo by injecting lentiviral vectors into lymph nodes, a novel approach being investigated at Exuma Biotech. Dr Kerkar explains how this process is much simpler and more cost-effective than traditional manufacturing processes and the exciting impact that this research may have in the future of hematological malignancies. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

свернуть